Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly E Dunn

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Drug and Alcohol Dependence|September 25, 2017
The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid useAndrew S Huhn, D Andrew Tompkins, Kelly E Dunn
Journal of Substance Abuse Treatment|December 28, 2020
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemicKelly E Dunn, Robert K Brooner, Kenneth B Stoller
Journal of Addiction Medicine|October 3, 2023
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured FentanylH Elizabeth Bird, Andrew S Huhn, Kelly E Dunn
Experimental and Clinical Psychopharmacology|February 24, 2011
Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patientsKelly E Dunn, Kathryn A Saulsgiver, Stacey C Sigmon
Frontiers in Psychiatry|May 2, 2022
Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid RelapseJustin C Strickland, Cassandra D Gipson, Kelly E Dunn
Journal of Addiction Medicine|August 7, 2019
Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing IndividualsAlexis S Hammond, Kelly E Dunn, Eric C Strain
JAMA Psychiatry|December 29, 2017
Tramadol Extended-Release and Opioid Withdrawal Management-Legal Implications-ReplyKelly E Dunn, D Andrew Tompkins, Eric C Strain
Journal of Substance Abuse Treatment|May 4, 2020
The impact of naturalistic cannabis use on self-reported opioid withdrawalCecilia L Bergeria, Andrew S Huhn, Kelly E Dunn
The American Journal on Addictions|May 28, 2019
Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use DisorderAndrew S Huhn, Meredith S Berry, Kelly E Dunn
Frontiers in Psychiatry|February 28, 2018
Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based InterventionsAndrew S Huhn, Albert Perez Garcia-Romeu, Kelly E Dunn
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Drug and Alcohol Dependence|September 25, 2017
The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid useAndrew S Huhn, D Andrew Tompkins, Kelly E Dunn
Journal of Substance Abuse Treatment|December 28, 2020
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemicKelly E Dunn, Robert K Brooner, Kenneth B Stoller
Journal of Addiction Medicine|October 3, 2023
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured FentanylH Elizabeth Bird, Andrew S Huhn, Kelly E Dunn
Experimental and Clinical Psychopharmacology|February 24, 2011
Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patientsKelly E Dunn, Kathryn A Saulsgiver, Stacey C Sigmon
Frontiers in Psychiatry|May 2, 2022
Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid RelapseJustin C Strickland, Cassandra D Gipson, Kelly E Dunn
Journal of Addiction Medicine|August 7, 2019
Drug Legalization and Decriminalization Beliefs Among Substance-using and Nonusing IndividualsAlexis S Hammond, Kelly E Dunn, Eric C Strain
JAMA Psychiatry|December 29, 2017
Tramadol Extended-Release and Opioid Withdrawal Management-Legal Implications-ReplyKelly E Dunn, D Andrew Tompkins, Eric C Strain
Journal of Substance Abuse Treatment|May 4, 2020
The impact of naturalistic cannabis use on self-reported opioid withdrawalCecilia L Bergeria, Andrew S Huhn, Kelly E Dunn
The American Journal on Addictions|May 28, 2019
Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use DisorderAndrew S Huhn, Meredith S Berry, Kelly E Dunn
Frontiers in Psychiatry|February 28, 2018
Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based InterventionsAndrew S Huhn, Albert Perez Garcia-Romeu, Kelly E Dunn
Pageof 17